Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
CHLORTETRACYCLINE HYDROCHLORIDE
Alpharma BVBA
QJ01AA03
100 mg/g
Premix for Med.Feedstuffs
Antibacterial
Fowl - Chicken
2001-04-22
IRISH MEDICINES BOARD ACT 1995 EUROPEAN COMMUNITIES (ANIMAL REMEDIES) (NO. 2) REGULATIONS 2007 (S.I. NO. 786 OF 2007) VPA: 10802/001/001 Case No: 7007489 The Irish Medicines Board in exercise of the powers conferred on it by Animal Remedies (No. 2) Regulations (S.I. No. 786 of 2007) hereby grants to: ALPHARMA BVBA LAARSTRAAT 16, 2610 ANTWERP, BELGIUM an authorisation, subject to the provisions of the said Regulations and the general conditions of the attached authorisation, in respect of the Veterinary Medicinal Product: AUROFAC 100 GRANULAR PREMIX FOR MEDICATED FEEDING The particulars of which are set out in Part 1 and Part 2 of the said Schedule. The authorisation is also subject to any special conditions as may be specified in the said Schedule. The authorisation,unless revoked, shall continue in force from 22/03/2010. Signed on behalf of the Irish Medicines Board ________________ A person authorised in that behalf by the said Board. (NOTE: This authorisation replaces any previous authorisation in respect of this product which is now null and void.) IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 23/03/2010_ _CRN 7007489_ _page number: 1_ PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Aurofac 100 Granular Premix for Medicated Feedingstuff 2 QUALITATIVE AND QUANTITATIVE COMPOSITION For a full list of excipients, see Section 6.1 3 PHARMACEUTICAL FORM Premix for medicated feeding stuff. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Pigs, chickens, turkeys and ducks. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES As an aid in the treatment and control of respiratory and systemic infections associated with chlortetracycline-sensitive organisms. 4.3 CONTRAI Read the complete document